NO933697L - Fremgangsm}te for screening av plasmapr!ver for effektiveantistoff-titere overfor respiratoriske virus - Google Patents

Fremgangsm}te for screening av plasmapr!ver for effektiveantistoff-titere overfor respiratoriske virus

Info

Publication number
NO933697L
NO933697L NO933697A NO933697A NO933697L NO 933697 L NO933697 L NO 933697L NO 933697 A NO933697 A NO 933697A NO 933697 A NO933697 A NO 933697A NO 933697 L NO933697 L NO 933697L
Authority
NO
Norway
Prior art keywords
virus
plasma
plasma samples
antibody titers
cells
Prior art date
Application number
NO933697A
Other languages
English (en)
Norwegian (no)
Other versions
NO933697D0 (no
Inventor
George R Siber
Jeanne Leszcynski
Original Assignee
Massachusetts Health Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Health Res filed Critical Massachusetts Health Res
Publication of NO933697D0 publication Critical patent/NO933697D0/no
Publication of NO933697L publication Critical patent/NO933697L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Control Of Indicators Other Than Cathode Ray Tubes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO933697A 1991-04-22 1993-10-14 Fremgangsm}te for screening av plasmapr!ver for effektiveantistoff-titere overfor respiratoriske virus NO933697L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68843591A 1991-04-22 1991-04-22
PCT/US1992/002958 WO1992018652A1 (en) 1991-04-22 1992-04-10 Process of screening plasma samples for effective antibody titers against respiratory viruses

Publications (2)

Publication Number Publication Date
NO933697D0 NO933697D0 (no) 1993-10-14
NO933697L true NO933697L (no) 1993-10-14

Family

ID=24764406

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933697A NO933697L (no) 1991-04-22 1993-10-14 Fremgangsm}te for screening av plasmapr!ver for effektiveantistoff-titere overfor respiratoriske virus

Country Status (13)

Country Link
US (2) US5412077A (de)
EP (1) EP0581882B1 (de)
JP (1) JPH06509866A (de)
AT (1) ATE161967T1 (de)
AU (2) AU668092B2 (de)
CA (1) CA2108259C (de)
DE (1) DE69223955T2 (de)
DK (1) DK0581882T3 (de)
ES (1) ES2113428T3 (de)
FI (1) FI110723B (de)
GR (1) GR3026393T3 (de)
NO (1) NO933697L (de)
WO (1) WO1992018652A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992018652A1 (en) * 1991-04-22 1992-10-29 Massachusetts Health Research Institute, Inc. Process of screening plasma samples for effective antibody titers against respiratory viruses
US5811524A (en) * 1995-06-07 1998-09-22 Idec Pharmaceuticals Corporation Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
US6969520B2 (en) * 1997-10-20 2005-11-29 Acambis Inc. Active immunization against clostridium difficile disease
EP2305303A3 (de) 1997-10-20 2013-11-13 Sanofi Pasteur Biologics Co. Immunisierung gegen Clostridium difficile-Erkrankung
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
EP2289550A3 (de) * 2000-01-27 2012-02-15 MedImmune, LLC Neutralisierende Antikörper mit ultrahoher Affinität
DK1259547T3 (da) 2000-03-01 2012-10-15 Medimmune Inc Højpotente, rekombinante antistoffer og fremgangsmåde til fremstilling heraf
US7179900B2 (en) * 2000-11-28 2007-02-20 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US6855493B2 (en) 2000-11-28 2005-02-15 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US20050153382A1 (en) * 2002-06-06 2005-07-14 Chengdu Kuachang Science And Technology Co., Ltd. Biochip kit comprising biochip based on antigen-antibody reactions, and its usage
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
WO2006050166A2 (en) * 2004-10-29 2006-05-11 Medimmune, Inc. Methods of preventing and treating rsv infections and related conditions
EP1997830A1 (de) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV-spezifische Bindemoleküle und Mittel zu ihrer Herstellung
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
TWI815599B (zh) 2011-04-22 2023-09-11 美商惠氏有限責任公司 與難養芽胞梭菌（Ｃｌｏｓｔｒｉｄｉｕｍ ｄｉｆｆｉｃｉｌｅ）之突變毒素有關之組成物及彼之方法
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
WO2021255690A2 (en) 2020-06-19 2021-12-23 Pfizer Inc. Immunogenic compositions against clostridioides (clostridium) difficile and methods thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315073A (en) * 1979-10-26 1982-02-09 Cutter Laboratories, Inc. Titration of serum influenza antibody using plaque reduction neutralization test
US4617379A (en) * 1983-06-14 1986-10-14 Miles Laboratories, Inc. High titer cytomegalovirus immune serum globulin
US4665379A (en) * 1984-05-10 1987-05-12 Anes Electronics, Inc. Vehicle security system
US4665159A (en) * 1985-11-07 1987-05-12 Miles Laboratories, Inc. High titer varicella-zoster immune globulin for intravenous administration
US4717766A (en) * 1986-01-27 1988-01-05 Miles Laboratories, Inc. Method of preparing high titer anti-respiratory syncytial virus intravenous immune globulin
US4800078A (en) * 1987-05-28 1989-01-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb
WO1992018652A1 (en) * 1991-04-22 1992-10-29 Massachusetts Health Research Institute, Inc. Process of screening plasma samples for effective antibody titers against respiratory viruses

Also Published As

Publication number Publication date
DK0581882T3 (da) 1998-09-07
US5412077A (en) 1995-05-02
US5582827A (en) 1996-12-10
DE69223955D1 (de) 1998-02-12
AU668092B2 (en) 1996-04-26
EP0581882A4 (en) 1994-06-08
DE69223955T2 (de) 1998-08-13
ES2113428T3 (es) 1998-05-01
FI934657L (fi) 1993-10-21
GR3026393T3 (en) 1998-06-30
FI934657A0 (fi) 1993-10-21
NO933697D0 (no) 1993-10-14
ATE161967T1 (de) 1998-01-15
JPH06509866A (ja) 1994-11-02
CA2108259A1 (en) 1992-10-23
WO1992018652A1 (en) 1992-10-29
AU6067896A (en) 1996-10-17
EP0581882B1 (de) 1998-01-07
CA2108259C (en) 2003-12-09
AU680170B2 (en) 1997-07-17
EP0581882A1 (de) 1994-02-09
AU1988592A (en) 1992-11-17
FI110723B (fi) 2003-03-14

Similar Documents

Publication Publication Date Title
NO933697L (no) Fremgangsm}te for screening av plasmapr!ver for effektiveantistoff-titere overfor respiratoriske virus
Mann et al. The effect of kaolin on immunoglobulins: an improved technique to remove the nonspecific serum inhibitor of reovirus hemagglutination
EP1801591A3 (de) Verfahren für den Nachweis oder die Messung von Viren
Pereira et al. Mechanism of hemagglutination by adenovirus types 1, 2, 4, 5 and 6
DANIELS Mechanisms of viral neutralization
EP0128522A3 (en) High titer cytomegalovirus immune serum globulin and method of making same
Meurman Detection of antiviral IgM antibodies and its problems—a review
Vejtorp Enzyme‐linked immunosorbent assay for determination of rubella IgG antibodies
ES8405952A1 (es) Un metodo de detectar un anticuerpo antivirus
Sarov et al. Enzyme linked immunosorbent assay (ELISA) for determination of IgG antibodies to human cytomegalovirus
Kreth et al. Cell-Mediated Cytotoxicity Against Measles Virus in SSPE: I. Enhancement by Antibody
Monath et al. Comparison of methods for removal of nonspecific inhibitors of arbovirus hemagglutination
WO1993025662A3 (en) Replication of hepatitis c virus genome and identification of virus having high infectivity
Bozicevich et al. The bentonite flocculation test for detection of plant viruses and titration of antibody
JPH05184361A (ja) 生物学的に活性なタンパク質の溶液中における低ｐＨでのリン酸トリ−（ｎ−ブチル）の殺ウイルス活性を増強するための使用
FI873233A0 (fi) Modifierade virala glykoproteiner.
DK162726C (da) Fremgangsmaade til eliminering af falsk positive resultater ved bestemmelse af atl virus-antistof og reagens dertil
Zhou et al. Development of an immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay for detection of equine and swine IgM antibodies to vesicular stomatitis virus
BE890338A (fr) Procede de preparation de solutions de lipoproteines a partir de residus de delipidation des plasmas et serums et utilisations de celles-ci
Payne et al. A radioimmunoassay for the cytoplasmic polyhedrosis virus from Bombyx mori
Cox et al. Hemolysis of PR8-virus sensitized erythrocytes.
Siber et al. Effective antibody titers against respiratory viruses
SU1467513A1 (ru) Способ определени антигенов вирусов
Jankowski et al. Study of interaction between IgG and IgM antibodies against rubella virus by the immunofluorescence method
Yaghoobizadeh et al. Preparation, purification and performance evaluation of polyclonal antibody against SARS-CoV-2 produced in rat

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application